Searchable abstracts of presentations at key conferences in endocrinology

ea0063p1192 | Thyroid 3 | ECE2019

Amiodarone-induced thyrotoxicosis: which type?

Gomes Vania , Castro Raquel Vaz de , Ferreira Florbela

Introduction: Amiodarone is a widely used antiarrhythmic drug for refractory atrial or ventricular tachyarrhythmias. Amiodarone-induced thyrotoxicosis (AIT) occurs in up to 6% of patients taking this medication in iodine-sufficient areas of the world and in up to 10% in iodine deficient areas. AIT can be divided into two types: type 1 is a form of iodine-induced hyperthyroidism whereas type 2 is a drug-induced destructive thyroiditis. Type 1 AIT tends to occur in patients with...

ea0056p66 | Adrenal cortex (to include Cushing's) | ECE2018

Evaluation of cardiometabolic profile of patients submitted to unilateral adrenalectomy

Castro Raquel Vaz de , Costa Cristiana , Matos Tania , Quadros Catarina , Lopez Dolores , Vale Sonia do , Bugalho Maria Joao

Background and aims: It is known that unilateral adrenalectomy as treatment for autonomous secreting adrenal cortex adenomas effectively reduces cardiometabolic risk. Non-autonomous secreting adenomas are not expected to increase cardiometabolic risk, but this has not been thoroughly explored.We evaluated the blood pressure and glycemic profile before and after unilateral adrenalectomy for both autonomous and non-autonomous secreting adrenal cortex adenomas.<p class="abste...